logo
  • SELECT LICENSE :

  • US $4,299.00
  • US $8,599.00

Pharmaceutical Grade Lactose Market, By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) opportunities and forecast 2020-2027

  • DLR2220
  • 20 September, 2020
  • Pharma & Healthcare
  • Pages: 120
  • Global
Market Overview

Growing demand in infant formulation, due to its brilliant characteristics including immune cell activation, iron absorption, and production of the cytokines, is likely to drive the market growth in the coming years.

Demand for the pharmaceutical grade lactose is anticipated to grow at significant rate due to its high demand as excipient in drug manufacturing industry. Furthermore, supportive government regulations, with low prices offered by the manufacturers, are anticipated to be the key factors prompting product demand in the pharmaceutical applications during the forecast period. The Environmental Protection Agency (EPA) in the U.S. is encouraging the sustainable and the cost-effective setup of various manufacturing facilities. Agency regulates discharges and effluents of such industrial holdings and has given standards for the same. However, stringent regulations are estimated to pose challenge for the industry players in coming years.

Segment Overview

Growing demand for product as drug carrier is anticipated to boost the industry growth over projected period. Increasing consumer disposable income, with growing consumer awareness concerning health and safety, is projected to have positive impact on the industry growth.

Regional Overview

Europe accounted for largest market share 2019 and is projected to reach considerable amount by 2026. This can be credited to the increased trend of outsourcing the pharmaceutical products in region, with presence of well-established healthcare sector in the region. Many initiatives by regional governments for the innovation and development of the product is likely to aid the market growth.
The North America market is benefitted primarily by presence of recognised players. In addition, growing demand for the infant formula in region is likely to boost the industry growth over the estimated period. Favourable government policies and growing investments by the regional players to develop competent products is projected to boost market growth.

Asia Pacific is anticipated to exhibit considerable growth over the estimate period, owing to the swelling birth rate in the developing economies such as India and China, leading to the growth in product demand for the infant formulation. Region is likely to witness rise in production ability owing to the lack of severe government regulations and low costs of labour.

Competitor overview

Major players in the market have been adopting numerous strategies, such as new product development, agreements, partnerships, collaborations, and the joint ventures, in order to cater to the changing technological necessities for diverse end-use applications.
Companies across the world are focusing on new strategies in order to gain competitive edge in the industry. Small-scale as well as established players are capitalising in R&D for the new cost-efficient methods to gain the market share. Participants are involved in establishing of new amenities to expand manufacturing capabilities.

Key Players
  1. Kerry Group
  2. Hilmar Ingredients
  3. Hoogwegt
  4. FrieslandCampina Domo
  5. Meggle Excipients & Technology
  6. Milei GmbH
  7. Fresenius Kabi Product Partnering
  8. Fonterra Co-Operative Group Ltd.
  9. Lactose (India) Limited
  10. Charotar Casein Company
Market Segmentation

By Geography
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • Rest of LAMEA


1 Report Prologue 10

    2 Market Introduction 13

    • 2.1 Introduction 13
    • 2.2 Scope of the Study 13
      • 2.2.1 Research Objective 13
      • 2.2.2 Assumptions 13
      • 2.2.3 Limitations 13
    • 2.3 Market Structure 14

    3 Research Methodology 15

    • 3.1 Primary Research Methodology 16
    • 3.2 Secondary Research Methodology 17
    • 3.3 Market Share Analysis 18
    • 3.4 Trade Analysis 18
    • 3.5 Market Pricing Approach 18

    4 Market Dynamics 19

    • 4.1 Introduction 19
    • 4.2 Drivers 20
      • 4.2.1 Increasing demand for dry powder inhalers (DPI) products (Impact Weightage: 30%) 20
      • 4.2.2 Compatibility with active ingredients and other excipients (Impact Weightage: 15%) 21
      • 4.2.3 Approval from government bodies (Impact Weightage: 25%) 22
      • 4.2.4 Drug formulation coupled with nanotechnology will boost the growth of pharmaceutical grade lactose market (Impact Weightage: 30%) 23
    • 4.3 Restrains 24
      • 4.3.1 Lactose-induced problems (Impact Weightage: 40%) 24
      • 4.3.2 Stringent government regulations (Impact Weightage: 30%)\ 25
      • 4.3.3 Lack compatibility with amine based drugs (Impact Weightage: 30%) 26
    • 4.4 Opportunity 27
    • 4.5 Mega Trends 27
      • 4.5.1 Using lactose as excipient in nanotechnology-based drug formulations 27
    • 4.6 Macroeconomic Indicators 27
    • 4.7 Technology Trends & Assessment 28

    5 Market Factor Analysis 29

    • 5.1 Value Chain Analysis 29
      • 5.1.1 R&D 29
      • 5.1.2 Manufacturing 29
      • 5.1.3 Distribution & Sales 30
      • 5.1.4 Post-sales Monitoring 30
    • 5.2 Porters Five Forces Model 31
      • 5.2.1 Bargaining power of suppliers (Medium to High) 32
      • 5.2.2 Bargaining Power of Buyers (low to medium) 32
      • 5.2.3 Threat of New Entrants (low to medium) 32
      • 5.2.4 Threat of Substitutes (High) 32
      • 5.2.5 Intensity of Rivalry (Medium) 32
    • 5.3 Demand & Supply: Gap Analysis 33
      • 5.3.1 Pricing Analysis 33
      • 5.3.2 Investment Opportunity Analysis 33

    6 Global Pharmaceutical Grade Lactose Market, by Type 34

    • 6.1 Introduction 34
    • 6.2 Crystalline Monohydrate Lactose 37
    • 6.3 Inhalation Lactose 38
    • 6.4 Granulated Lactose 39
    • 6.5 Spray Dried Lactose 40

    7 Global Pharmaceutical Grade Lactose Market, by Application 41

    • 7.1 Introduction 41
    • 7.2 Tablets Manufacturing 43
    • 7.3 Capsule Manufacturing 44

    8 Global Pharmaceutical Grade Lactose Market, by Region 45

    • 8.1 Introduction 45
    • 8.2 Europe 47
      • 8.2.1 Western Europe 51
        • 8.2.1.1 Germany 53
        • 8.2.1.2 France 55
        • 8.2.1.3 U.K. 57
        • 8.2.1.4 Italy 59
        • 8.2.1.5 Spain 61
        • 8.2.1.6 Rest of Western Europe 62
      • 8.2.2 Eastern Europe 65
    • 8.3 Asia Pacific 67
      • 8.3.1 Japan 71
      • 8.3.2 China 73
      • 8.3.3 India 75
      • 8.3.4 Republic of Korea 77
      • 8.3.5 Australia 79
      • 8.3.6 Rest of Asia Pacific 81
    • 8.4 Americas 83
      • 8.4.1 North America 86
        • 8.4.1.1 U.S. 88
        • 8.4.1.2 Canada 90
      • 8.4.2 South America 92
    • 8.5 Middle East & Africa 94
      • 8.5.1 Middle East 97
      • 8.5.2 Africa 99

    9 Company Landscape 101

    • 9.1 Company Share Analysis 101
    • 9.2 Competitive Landscape 102

    10 Company Profiles 103

    • 10.1 BASF SE 104
      • 10.1.1 Company Overview 104
      • 10.1.2 Financials 104
      • 10.1.3 Products 104
      • 10.1.4 Strategy 104
      • 10.1.5 Key Developments 104
    • 10.2 Merck KGaA 106
      • 10.2.1 Company Overview 106
      • 10.2.2 Financials 106
      • 10.2.3 Products 106
      • 10.2.4 Strategy 106
      • 10.2.5 Key Developments 106
    • 10.3 Kerry Inc. 108
      • 10.3.1 Company Overview 108
      • 10.3.2 Financials 108
      • 10.3.3 Products 108
      • 10.3.4 Strategy 108
      • 10.3.5 Key Developments 108
    • 10.4 DFE Pharma 110
      • 10.4.1 Company Overview 110
      • 10.4.2 Financials 110
      • 10.4.3 Products 110
      • 10.4.4 Strategy 110
      • 10.4.5 Key Developments 110
    • 10.5 Meggle 111
      • 10.5.1 Company Overview 111
      • 10.5.2 Financials 111
      • 10.5.3 Products 111
      • 10.5.4 Strategy 111
      • 10.5.5 Key Developments 111
    • 10.6 Armor Pharma 112
      • 10.6.1 Company Overview 112
      • 10.6.2 Financials 112
      • 10.6.3 Products 112
      • 10.6.4 Strategy 112
      • 10.6.5 Key Developments 112
    • 10.7 ALPAVIT 113
      • 10.7.1 Company Overview 113
      • 10.7.2 Financials 113
      • 10.7.3 Products 113
      • 10.7.4 Strategy 113
      • 10.7.5 Key Developments 113

    11 MRFR Conclusion 114

    • 11.1 Key Findings 114
      • 11.1.1 From CEO’s view point 114
    • 11.2 Key Companies to Watch 114

    12 Appendix 115

    • 12.1 Discussion Blue Print 115

    Report You Might be Interested